The U.S. federal biomedical research agency
Kennedy has led a push to pull government flu-vaccine advertising amid a broader shift at HHS, with emails showing internal debate and political direction shaping public-health messaging during a severe flu season. The disclosures show tension between Kennedy’s policy moves and CDC leadership as a new administration implements its agenda.